SUPERIOR EFFICACY OF VTD OVER VCD BEFORE AND AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA

被引：0
作者：
Cavo, M. [1 ]
Pantani, L. [1 ]
Pezzi, A. [1 ]
Cavallo, F. [2 ]
Petrucci, M. T. [2 ]
Di Raimondo, F. [2 ]
Patriarca, F. [2 ]
Zamagni, E. [1 ]
Montefusco, V. [2 ]
Galli, M. [2 ]
Gamberi, B. [2 ]
Rossi, G. [2 ]
Tacchetti, P. [1 ]
Grasso, M. [2 ]
Offidani, M. [2 ]
Ballanti, S. [2 ]
Zambello, R. [2 ]
Liberati, A. M. [2 ]
Bassan, R. [2 ]
Pregno, P. [2 ]
Palumbo, A. [2 ]
机构：
[1] Univ Sch Med, Inst Hematol L & A Seragnoli, Bologna, Italy
[2] GIMEMA Myeloma Network, Rome, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C057
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [41] Autologous Stem Cell Transplantation in Newly Diagnosed Elderly Multiple Myeloma Patients: A Single Centre Experience
    Berno, Tamara
    Riva, Marcello
    Ammirati, Lucia
    Brugnaro, Luca
    Gurrieri, Carmela
    Branca, Antonio
    Mitja, Nabergoj
    Visentin, Andrea
    Imbergamo, Silvia
    Piazza, Francesco
    Trentin, Livio
    Zambello, Renato
    Semenzato, Gianpietro
    BLOOD, 2017, 130
  • [42] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Egerer, G.
    Hose, D.
    Sauer, S.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ONKOLOGIE, 2013, 36 : 152 - 152
  • [43] Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update
    Bazarbachi, Abdul Hamid
    Al Hamed, Rama
    Malard, Florent
    Bazarbachi, Ali
    Harousseau, Jean-Luc
    Mohty, Mohamad
    BLOOD CANCER JOURNAL, 2022, 12 (03)
  • [44] MINIMAL RESIDUAL DISEASE (MRD) RATIO BEFORE AND AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)
    Antonioli, E.
    Nozzoli, C.
    Staderini, M.
    Boncompagni, R.
    Caporale, R.
    Peruzzi, B.
    Bosi, A.
    Saccardi, R.
    HAEMATOLOGICA, 2019, 104 : 66 - 66
  • [45] The Continued and Often Underappreciated Benefits of Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma (NDMM)
    Callander, Natalie S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S130 - S133
  • [46] A SINGLE CENTRE EXPERIENCE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS
    Riva, M.
    Ammirati, L.
    Visentin, A.
    Gurrieri, C.
    Branca, A.
    Scapinello, G.
    Barila, G.
    Imbergamo, S.
    Piazza, F.
    Trentin, L.
    Zambello, R.
    Semenzato, G.
    Berno, T.
    HAEMATOLOGICA, 2019, 104 : 166 - 166
  • [47] Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma
    Bove, Virginia
    Garrido, David
    Riva, Eloisa
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (03) : 295 - 302
  • [48] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Sauer, S.
    Egerer, G.
    Hundemer, M.
    Hose, D.
    Kunz, C.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 189 - 195
  • [49] Stem cell mobilization and autologous stem cell transplantation after induction with Bendamustine, Prednisone and Bortezomib (BPV) in newly diagnosed multiple myeloma patients
    Wang, S. -Y.
    Fricke, S.
    Holzhey, T.
    Andrea, M.
    Holzvogt, M.
    Vucinic, V.
    Franke, G. -N.
    Heyn, S.
    Hell, S.
    Jentzsch, M.
    Scholz, M.
    Platzbecker, U.
    Merz, M.
    Poenisch, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 178 - 178
  • [50] Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update
    Abdul Hamid Bazarbachi
    Rama Al Hamed
    Florent Malard
    Ali Bazarbachi
    Jean-Luc Harousseau
    Mohamad Mohty
    Blood Cancer Journal, 12
12345